Andrew Jennings

Andrew Jennings has a diverse work experience starting from their role as a Senior Associate at KPMG Audit, where they managed audit procedures and client communication. Andrew then worked as a Financial Analyst at Endo Pharmaceuticals Inc. Following this, they joined ViroPharma Incorporated as the Manager of Forecasting and G&A, where they managed strategic planning, financial modeling, resource allocation, and implemented a new management reporting model. After that, they worked at Egalet Corporation as the Director of Financial Reporting and later as the Corporate Controller, responsible for SEC filings, monthly close activities, and leading an Oracle implementation project. Currently, they are the Director of Financial Planning and Analysis at Zynerba Pharmaceuticals, overseeing financial projections, budgeting, reporting, and cash forecasting processes.

Andrew Jennings attended Lehigh University from 2002 to 2006, where they earned a Bachelor of Science degree in Accounting.